NM_001378964.1:c.350-13T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378964.1(CDON):​c.350-13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0925 in 1,601,770 control chromosomes in the GnomAD database, including 7,248 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 863 hom., cov: 32)
Exomes 𝑓: 0.091 ( 6385 hom. )

Consequence

CDON
NM_001378964.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.647

Publications

6 publications found
Variant links:
Genes affected
CDON (HGNC:17104): (cell adhesion associated, oncogene regulated) This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
CDON Gene-Disease associations (from GenCC):
  • holoprosencephaly 11
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Illumina
  • pituitary stalk interruption syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 11-126019778-A-G is Benign according to our data. Variant chr11-126019778-A-G is described in ClinVar as Benign. ClinVar VariationId is 260795.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.122 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDONNM_001378964.1 linkc.350-13T>C intron_variant Intron 3 of 19 ENST00000531738.6 NP_001365893.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDONENST00000531738.6 linkc.350-13T>C intron_variant Intron 3 of 19 1 NM_001378964.1 ENSP00000432901.2 Q4KMG0-2E9PN78

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15804
AN:
152130
Hom.:
860
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.114
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.0980
Gnomad EAS
AF:
0.121
Gnomad SAS
AF:
0.121
Gnomad FIN
AF:
0.127
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.0879
Gnomad OTH
AF:
0.100
GnomAD2 exomes
AF:
0.109
AC:
27022
AN:
248602
AF XY:
0.107
show subpopulations
Gnomad AFR exome
AF:
0.118
Gnomad AMR exome
AF:
0.144
Gnomad ASJ exome
AF:
0.103
Gnomad EAS exome
AF:
0.136
Gnomad FIN exome
AF:
0.129
Gnomad NFE exome
AF:
0.0859
Gnomad OTH exome
AF:
0.100
GnomAD4 exome
AF:
0.0913
AC:
132284
AN:
1449522
Hom.:
6385
Cov.:
28
AF XY:
0.0916
AC XY:
66124
AN XY:
721940
show subpopulations
African (AFR)
AF:
0.111
AC:
3687
AN:
33198
American (AMR)
AF:
0.141
AC:
6294
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
2675
AN:
26068
East Asian (EAS)
AF:
0.123
AC:
4856
AN:
39608
South Asian (SAS)
AF:
0.116
AC:
9964
AN:
86024
European-Finnish (FIN)
AF:
0.125
AC:
6604
AN:
52698
Middle Eastern (MID)
AF:
0.0709
AC:
396
AN:
5588
European-Non Finnish (NFE)
AF:
0.0835
AC:
91984
AN:
1101694
Other (OTH)
AF:
0.0971
AC:
5824
AN:
59972
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
5192
10383
15575
20766
25958
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3510
7020
10530
14040
17550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15836
AN:
152248
Hom.:
863
Cov.:
32
AF XY:
0.106
AC XY:
7888
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.114
AC:
4737
AN:
41534
American (AMR)
AF:
0.126
AC:
1930
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0980
AC:
340
AN:
3470
East Asian (EAS)
AF:
0.122
AC:
634
AN:
5182
South Asian (SAS)
AF:
0.122
AC:
588
AN:
4822
European-Finnish (FIN)
AF:
0.127
AC:
1347
AN:
10608
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0879
AC:
5978
AN:
68018
Other (OTH)
AF:
0.104
AC:
220
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
730
1459
2189
2918
3648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0954
Hom.:
143
Bravo
AF:
0.103
Asia WGS
AF:
0.162
AC:
562
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 11 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
5.3
DANN
Benign
0.72
PhyloP100
-0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3740910; hg19: chr11-125889673; COSMIC: COSV54996157; COSMIC: COSV54996157; API